Home Cart 0 Sign in  

[ CAS No. 27975-19-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 27975-19-5
Chemical Structure| 27975-19-5
Structure of 27975-19-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 27975-19-5 ]

Related Doc. of [ 27975-19-5 ]

Alternatived Products of [ 27975-19-5 ]

Product Details of [ 27975-19-5 ]

CAS No. :27975-19-5 MDL No. :MFCD28411514
Formula : C20H30O3 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 318.45 Pubchem ID :-
Synonyms :
(-)-Isosteviol
Chemical Name :(4R,4aS,6aR,9S,11aR,11bS)-4,9,11b-Trimethyl-8-oxotetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylic acid

Calculated chemistry of [ 27975-19-5 ]

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.9
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 90.73
TPSA : 54.37 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.15 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.63
Log Po/w (XLOGP3) : 4.35
Log Po/w (WLOGP) : 4.44
Log Po/w (MLOGP) : 3.75
Log Po/w (SILICOS-IT) : 4.14
Consensus Log Po/w : 3.86

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -4.49
Solubility : 0.0103 mg/ml ; 0.0000324 mol/l
Class : Moderately soluble
Log S (Ali) : -5.21
Solubility : 0.00198 mg/ml ; 0.00000621 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.21
Solubility : 0.0195 mg/ml ; 0.0000611 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.83

Safety of [ 27975-19-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 27975-19-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 27975-19-5 ]
  • Downstream synthetic route of [ 27975-19-5 ]

[ 27975-19-5 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 57817-89-7 ]
  • [ 27975-19-5 ]
YieldReaction ConditionsOperation in experiment
93% With sulfuric acid In water Ent-16-oxobeyeran-19-oic acid was synthesized by hydrolysis of stevioside with 10percent sulfuric acid
[48]
.
Yield 93percent; Mp 228.4-230.8 °C; IR (KBr): 3448, 2955, 2924, 2848, 1736, 1692, 1453, 1404, 1373, 1320, 1268, 1214, 1180, 1150, 1108, 973, 950, 796, 589 cm-1; 1H NMR (400 MHz, CDCl3, ppm): δ 2.64 (dd, J = 18.64, 3.76 Hz, 1H), 2.17 (d, J = 13.40 Hz, 1H), 1.90-1.37 (m, 13H), 1.25 (s, 3H), 1.22-1.14 (m, 3H), 1.06-1.03 (m, 1H), 0.98 (s, 3H), 0.95-0.88 (m, 1H), 0.78 (s, 3H); 13C NMR (100 MHz, CDCl3, ppm): δ 224.22, 184.33, 56.79, 57.62, 56.09, 54.83, 49.73, 49.59, 44.38, 42.02, 40.42, 40.42, 38.99, 38.34, 32.80, 29.69, 22.32, 20.57, 19.55, 14.04; HRMS (ESI, m/z) calcd for C20H30O3Na [M + Na]+ 341.2093. Found: 341.2085.
Reference: [1] Chemistry and Biodiversity, 2013, vol. 10, # 2, p. 177 - 188
[2] Bioorganic and Medicinal Chemistry Letters, 1997, vol. 7, # 19, p. 2485 - 2490
[3] European Journal of Medicinal Chemistry, 2016, vol. 115, p. 26 - 40
[4] Journal of Chemical Crystallography, 2009, vol. 39, # 2, p. 108 - 111
[5] Journal of Chemical Crystallography, 2011, vol. 41, # 4, p. 519 - 522
[6] Journal of Natural Products, 2002, vol. 65, # 3, p. 273 - 277
[7] Life Sciences, 2005, vol. 77, # 17, p. 2127 - 2140
[8] Journal of the American Chemical Society, 2007, vol. 129, # 41, p. 12453 - 12460
[9] Patent: EP1757282, 2007, A1, . Location in patent: Page/Page column 10
[10] Planta Medica, 2008, vol. 74, # 8, p. 816 - 821
[11] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 4, p. 1464 - 1473
[12] European Journal of Medicinal Chemistry, 2013, vol. 65, p. 70 - 82
[13] Life Sciences, 2014, vol. 116, # 1, p. 31 - 36
[14] Food Chemistry, 2016, vol. 190, p. 270 - 275
[15] Patent: CN108456240, 2018, A, . Location in patent: Paragraph 0063-0065
  • 2
  • [ 58543-16-1 ]
  • [ 27975-19-5 ]
  • [ 29584-19-8 ]
  • [ 129836-86-8 ]
Reference: [1] Phytochemistry Letters, 2018, vol. 25, p. 163 - 170
  • 3
  • [ 57817-89-7 ]
  • [ 27975-19-5 ]
Reference: [1] Phytochemistry, 1996, vol. 43, # 2, p. 393 - 395
[2] Journal of Natural Products, 2004, vol. 67, # 3, p. 407 - 410
[3] Patent: US9314438, 2016, B2, . Location in patent: Page/Page column 26; 27
  • 4
  • [ 29584-19-8 ]
  • [ 27975-19-5 ]
Reference: [1] Journal of Organic Chemistry, 1955, vol. 20, p. 884,895
[2] Journal de Pharmacie et de Chimie, 1931, vol. <8> 14, p. 321,325, 369, 372[3] Bulletin de la Societe de Chimie Biologique, 1931, vol. 13, p. 781,785, 790
[4] Food Chemistry, 2016, vol. 190, p. 270 - 275
  • 5
  • [ 1347574-22-4 ]
  • [ 27975-19-5 ]
Reference: [1] Molecules, 2011, vol. 16, # 5, p. 3552 - 3562
  • 6
  • [ 23963-60-2 ]
  • [ 1012876-81-1 ]
  • [ 27975-19-5 ]
  • [ 89470-25-7 ]
Reference: [1] Phytochemistry, 2009, vol. 70, # 6, p. 759 - 764
  • 7
  • [ 23963-60-2 ]
  • [ 1012876-90-2 ]
  • [ 1012876-81-1 ]
  • [ 1012876-88-8 ]
  • [ 1168152-25-7 ]
  • [ 27975-19-5 ]
  • [ 89470-25-7 ]
Reference: [1] Phytochemistry, 2009, vol. 70, # 6, p. 759 - 764
  • 8
  • [ 7664-93-9 ]
  • [ 29584-19-8 ]
  • [ 27975-19-5 ]
Reference: [1] Journal de Pharmacie et de Chimie, 1931, vol. <8> 14, p. 321,325, 369, 372[2] Bulletin de la Societe de Chimie Biologique, 1931, vol. 13, p. 781,785, 790
  • 9
  • [ 50-99-7 ]
  • [ 7664-93-9 ]
  • [ 57817-89-7 ]
  • [ 27975-19-5 ]
Reference: [1] Journal de Pharmacie et de Chimie, 1931, vol. <8> 14, p. 99,100[2] Bulletin de la Societe de Chimie Biologique, 1931, vol. 13, p. 636,645, 656
Same Skeleton Products
Historical Records